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Abstract: Objectives: To assess the cost-effectiveness of workplace-delivered interventions designed
to reduce sitting time as primary prevention measures for cardiovascular disease (CVD) in Australia.
Methods: A Markov model was developed to simulate the lifetime cost-effectiveness of a workplace
intervention for the primary prevention of CVD amongst office-based workers. An updated
systematic review and a meta-analysis of workplace interventions that aim to reduce sitting time
was conducted to inform the intervention effect. The primary outcome was workplace standing
time. An incremental cost-effectiveness ratio (ICER) was calculated for this intervention measured
against current practice. Costs (in Australia dollars) and benefits were discounted at 3% annually.
Both deterministic (DSA) and probabilistic (PSA) sensitivity analyses were performed. Results:
The updated systematic review identified only one new study. Only the multicomponent intervention
that included a sit-and-stand workstation showed statistically significant changes in the standing
time compared to the control. The intervention was associated with both higher costs ($6820 versus
$6524) and benefits (23.28 versus 23.27, quality-adjusted life year, QALYs), generating an ICER
of $43,825/QALY. The DSA showed that target age group for the intervention, relative risk of
CVD relative to the control and intervention cost were the key determinants of the ICER. The base
case results were within the range of the 95% confidence interval and the intervention had a
85.2% probability of being cost-effective. Conclusions: A workplace-delivered intervention in the
office-based setting including a sit-and-stand desk component is a cost-effective strategy for the
primary prevention of CVD. It offers a new option and location when considering interventions to
target the growing CVD burden.
Keywords: sedentary behaviour; workplace intervention; multicomponent; cost-effective analysis;
cardiovascular disease; primary prevention
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1. Introduction
Cardiovascular disease (CVD) has been the dominant cause of mortality in Australia for the past
several decades, with coronary heart disease (CHD) and stroke ranking the highest among the leading
causes of death [1,2].
CVD is considered largely preventable by modification of related risk factors, like smoking,
obesity, physical inactivity, inadequate consumption of fruits and vegetables, high levels of blood
glucose, blood pressure and lipids. Ninety percent of Australian adults have at least one modifiable
risk factor for CVD, while 64% have three or more [3]. For instance, 90% of the risk associated with
myocardial infarction (MI) worldwide is attributable to these risk factors [4]. Although mortality
due to CVD is expected to decline over time given advancements in prevention, early diagnosis and
treatment, the total CVD burden is estimated to increase over the next few decades given the ageing
population[1].
Primary prevention offers the best option for tackling the growing prevalence of CVD worldwide.
Australian and international primary care guidelines unanimously emphasise comprehensive risk
assessment to enable effective management of identified modifiable risk factors through lifestyle
changes and/or pharmacological therapy [5–7].
The link between excessive sitting time and adverse health outcomes, including CVD, type 2
diabetes and premature mortality, has been well recognised even after accounting for the influence of
moderate to vigorous physical activity [8,9]. Persons who sit 8 to 11 hours per day have an estimated
15% increased risk of death over the next three years compared to those who sit less than 4 hours per
day [10]. Too much sitting has become a key public health concern [11], since sedentary behaviour
occupies more than half of adults’ waking hours [12]. In office workers, workplace sitting is the
single biggest contributor to daily sitting time [13]. Further, as office-based workers constitute the
largest occupational sector and the proportion of industrial work that involves sedentary activity is
increasing [14], the office workplace has been identified as a key setting in which to reduce prolonged
sitting time [15].
In contrast to the detrimental effects of prolonged sitting, large scale prospective observational
studies have reported that time spent standing is linked to a reduction in all-cause mortality risk in a
dose-response manner [16,17]. Furthermore, analyses using isotemporal substitution modelling have
shown that replacing sitting time with equal amounts of standing is linked to substantial mortality risk
reduction in Australian adults [18]. In the workplace context, a reduction in time spent sitting results
in increased physical activity that is usually of light intensity, including increased standing. Recent
workplace intervention trials in Australia and the UK using device-based measures have reported that
the ~42 minute reduction seen in workplace sitting at 12 months is almost entirely achieved by an
equivalent increase in standing [19,20]. In the Australian study, the intervention resulted in a small
benefit for fasting glucose and the overall cardiometabolic risk score at 12 months [21]. Collectively,
the observational and intervention evidence suggests that workplace approaches leading to modest
reductions in sitting time through increased standing may have some benefit for CVD prevention in
the long-term.
To date, none of the studies evaluating interventions that reduce workplace sitting time and
increase standing time report participant outcomes in the period after the end of the intervention due
primarily to insufficient length of follow-up. Therefore, the effectiveness of interventions that decrease
workplace sitting time in reducing the prevalence of CVD events and their associated long-term
cost-effectiveness credentials remain unknown.
The current study aimed to (i) systematically identify workplace-delivered interventions targeted
at reducing sitting time of office-based workers leading to increased standing; (ii) simulate the
long-term CVD outcomes associated with these interventions; and (iii) assess their cost-effectiveness.
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2. Methods
2.1. Systematic Review of Evidence
Search Strategy
To the best of our knowledge, there has been only one systematic review of workplace
interventions for reducing sitting time in office workplaces [22], their search was conducted on
9 August 2017. An updated literature search was undertaken to identify any new studies published
thereafter in Medline (plus PsyInfo via EBSCO) and Embase (see Appendix A for search strategy).
The search was carried out on 10 July 2018 using the same search terms and inclusion and exclusion
criteria as reported in the systematic review by Shrestha [22]. Briefly, workplace interventions usually
comprised of multiple components such as sit-stand desk, counselling, active workstation (i.e., desks
that can substantially promote energy expenditure compared to sit-desks), information/feedback
and/or reminder, computer prompts, mindfulness training, activity tracker, organisational support. In
the study by Shrestha, only those multi-component interventions involving a sit-and-stand desk were
able to significantly reduce the workplace sitting time with most of the evidence being of low quality
due to the limitation in study protocols and small sample sizes [22]. Risk of bias was assessed using
Cochrane Risk of bias tool [23].
If more than one study was identified, the effect size was meta-analysed in Review Management
(RevMan) 5.1 (Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014, London,
UK) using minutes of standing time (per eight hours of working time), incorporating the inverse
variance method with random effects model. Trials with unadjusted estimates of intervention effects
were calculated from the raw data provided in published papers. Heterogeneity was assessed using
the I2 statistic.
2.2. Modelling the Long-Term CVD Outcome
2.2.1. Population
Office-based workers in Australia aged between 30 and 65 years and without prior history of
CVD were modelled. The modelled population was divided into 5-year age and gender groups based
on Australia Bureau of Statistics (ABS) data [24], with average weight of each group derived from the
2014-15 Australia National Health Survey [25].
2.2.2. Model Structure
A pre-existing Markov model consisting of seven health states (healthy, post-coronary heart
disease (CHD), post-stroke, death due to incident CHD, death due to incident stroke, death post-CHD,
death post-stroke and death due to all other causes) was used [26–28] (Figure S1). Only CHD and
stroke were modelled since these two events account for the majority of total CVD events [29]. Ischemic
and haemorrhagic stroke were not separately simulated, however, the difference in case fatality of
these two types of stroke was taken into consideration. All persons in the hypothetical cohort started
from a healthy state. In each Markov cycle, healthy subjects may stay healthy, have a CHD or stroke
event (fatal or non-fatal) or die from other non-CVD causes. For subjects who experience CVD, they
either survive or die from the event. CVD survivors transit to the post-CHD or post-stroke health
state corresponding to the CVD event that occurred in the previous cycle. To simplify the model and
given our primary prevention focus, only an individual’s first CVD event was simulated over their
lifetime. The modelling was performed using TreeAge (TreeAge Pro 2018, R2.1. TreeAge Software,
Williamstown, MA, USA).
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2.2.3. Outcome Measures
Increases in standing time (min/week) was selected as the intervention effect, given that reduction
in sitting time is mostly replaced by standing time. Studies that have used objective measures of sitting,
standing and stepping allow ascertainment of the activities replacing sitting time) and most studies
report this outcome. Increase in time spent standing was multiplied by the metabolic equivalent
units (MET) associated with standing and then converted to energy expenditure using the following
equation [30]
Energy expenditure (Kcal/min) =
MET × 3.5 × Body weight (kg)
200
(1)
Given insufficient evidence of decay effects, it was hypothesised that the increase in standing time
was sustained until 5 years post intervention, which is consistent with a previous modelled economic
study around physical activity interventions [31].
2.2.4. Disease Inputs
The baseline incidence (The 28 day survival incidence was defined as the number of people
who survive the first 28-days after a first ever CHD or stroke event divided by the total number of
population in that age and gender group) of CHD and stroke and mortality from all other causes were
extracted from the Australian Burden of Disease study [32]. The 28-day and post-28 day case fatality
rates of CHD and stroke were derived from previous studies of primary prevention interventions for
CVD in Australia [26,27]. The probabilities of non-fatal CVD events in the first year were computed
using CVD incidence, post-28 day case fatality and CVD incidence trends [26]. The incidence and case
fatality of CHD and stroke were assumed to decline over time at a rate of 2.0% annually [28], given
advancements in disease prevention and management. Mortality due to all other causes was assumed
to decrease at a rate less than incidence and case fatality [28]. It was assumed that the changes in
disease and mortality trends were maintained for 10 years only and thereafter remained constant.
Studies have shown that physical activity as measured by energy expenditure is associated with
reduced occurrence of CVD events in healthy populations [33]. Therefore, in order to adjust for the
reduced incidence of these CVD events in the intervention group, the relative risks (RR) of CHD
and stroke corresponding to different intensities of energy expenditure between the intervention and
control groups were applied.
2.2.5. Costs
An Australian healthcare system perspective was adopted for the measurement of costs.
Productivity gains or losses associated with the intervention were excluded. Costs of each of the
workplace-delivered interventions were assigned as one-off costs and based on published literature
where applicable. The unit costs of treating an incident case of CHD and stroke were sourced from
the Independent Hospital Pricing Agency (IHPA), Australia, while management costs attributable to
ongoing CHD and stroke care were derived from published literature. All costs were expressed in
Australian dollars (AUD) for the 2016 reference year (Appendix A Table A1).
2.2.6. Utility Weights
A utility weight was attached to the time spent in each health state to capture the average quality
of life experienced by each age and gender group; quality-adjusted life years (QALY) were accrued
over the entire time horizon of the model (Appendix A Table A1). Separate utility weights were
derived from the published literature for patients with CHD and stroke.
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2.2.7. Cost-Effectiveness Analysis
Using the Markov model prediction of QALYs lived and costs over the cohort’s lifetime for both
the intervention and control group, an incremental cost-effectiveness ratio (ICER) was calculated,
with future costs and benefits discounted at 3% annually [34]. One-way sensitivity analyses were
conducted to test the robustness of the base-case results. Where applicable, key model parameters were
varied within a particular range (based on the best available evidence or a 20% increase or decrease
in costs where data were insufficient to inform the range). One-way sensitivity analyses results are
shown in a Tornado diagram, which graphs sequentially the variables with the largest impact on the
cost-utility results.
Probabilistic sensitivity analyses (PSA) were performed to assess the overall impact of uncertainty
in the model by defining distributions of key model parameters (i.e., transition probabilities, utility
weights and costs). Five thousand iterations (i.e., second-order Monte Carlo simulations) were run
to obtain a mean and 95% confidence interval for the corresponding costs and benefits; the results
were plotted on a cost-effectiveness plane. The often cited willingness-to-pay (WTP) per QALY of
AUD50,000 [35] was adopted to determine the cost-effectiveness of the individual workplace-delivered
interventions, with an acceptability curve generated for each interventions.
If the intervention was implemented nationally, it was conservatively assumed that 20% of the
entire Australian workforce (45%) who work in a sedentary occupation would participate [36].
2.2.8. Ethical Statement
Since all the data used to inform the health economic model were sourced from published
literature, the ethics approval was not required.
3. Results
3.1. Systematic Review of Workplace Interventions to Reduce Sitting Time
The most recent systematic review of workplace interventions targeting sedentary activity
compared the effectiveness of different interventions [22] which included one or more of the following
components:
i. Physical changes in workplace design and environment including changes in desks, chairs and
workplace layout;
ii. Policies to modify the organisation of work including arranging walking meetings, encouraging
breaks and completing sitting diaries;
iii. Provision of information and counselling including signs or prompts at the workplace, e-health
interventions, distribution of leaflets and counselling.
In addition to the above inclusion criteria, our study stipulated that for interventions involving a
sit-and-stand desk, each participant was allocated a sit-and-stand desk for use over the entire duration
of their work hours (rather than occasional use subject to availability).
Our updated literature search identified 579 additional articles published between August 2017
and July 2018. After screening titles and abstracts, 475 articles were excluded due to irrelevance. Eleven
articles were reviewed on a full-text basis, resulting in nine being excluded due to ineligible study
design (N = 5), wrong outcome (N = 2) and different setting of interest (N = 2). Eventually, one new
study was included in our systematic review [19,37,38] (the previous systematic review included
19 studies in the meta-analysis [22]) (see Appendix A Figure A1).
The newly identified study, Zhu 2018 [37] was a cluster randomised controlled trial (cRCT) which
enrolled participants from the United States. Work sites were randomised into intervention or control;
office-based workers in the intervention arm received a multi-component intervention involving a
sit-and-stand workstation during both an active (4 months) and a maintenance phase (14 months).
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The characteristics and risk of bias assessment of the additional study are summarised in Appendix A
Table A2.
Given that the sample size of studies included in the original systematic review (Analysis 1.6)
ranged from 16 to 44 [22] and only the short-term outcomes (i.e., month 3) were meta-analysed, it
was considered inappropriate to meta-analyse them with the addition of the newly identified study.
Another reason was the heterogeneity in study design; the sit-and-stand desk was not necessarily
assigned to each trial participant on a one-to-one basis (e.g., sit-and-stand desk provided in common
area or only for the first 3 months), Hence, it was decided in the base case analysis of the current study,
for the intervention involving a sit-and-stand desk, that the intervention effect size would be based on
meta-analysis of two studies only (Healy 2016 plus the newly identified study Zhu 2018) at month 12,
whilst in the sensitivity analysis, the results from the study with the largest sample size (i.e., Healy
2016) were used (Figure S2).
For all the other interventions, the model inputs in terms of the changes in standing time are
summarised in Table 1.
Table 1. Meta-analysed results of reduction in standing time for different types of workplace
interventions.
Intervention Comparator Changes in Standing Time(Min/Day, 95% CI) p-Value
Sit-stand desk with or without
information and counselling Sit-desk 40.85 (26.18, 59.42) * p < 0.001
Information, feedback and/or reminder No intervention 10.24 (−17.17, 37.65) p > 0.05
Prompts plus information Information alone 32.40 (−6.81, 71.61) p > 0.05
Computer prompts to step Computer prompts to stand −11.9 (−15.33, −8.47) p > 0.05
Activity tracker combined with
organisational support Organisation support 3.40 (−19.80, 26.60) p > 0.05
Footnote: the results except for the first row are sourced from the previous Cochrane systematic review [22].
* long-term results only.
3.2. Results of Modelling
3.2.1. Cost-Effectiveness Analysis
Implementation of the intervention involving a sit-and-stand workstation component was
associated with both higher benefits (23.280 QALYs versus 23.273 QALYs) and costs ($6820 versus
$6524). The resultant ICER was $43,825 per QALY gained, which makes it cost-effective. If the
intervention was scaled up to 20% of the national office-based workforce, it would result in a total gain
of 4335 QALYs for an additional total cost of $267M (the cost offset due to avoided CVD was $83M).
Specifically, it could potentially avoid 70 incident non-fatal CHD and 20 incident fatal CHD events
per 100,000 population whereas no difference in terms of fatal or non-fatal event of stroke (results
generated from the economic model).
3.2.2. Sensitivity Analysis
The base case results were most sensitive to the target age group for the intervention, RR of CHD
and stroke relative to the control, the intervention cost and discount rate (Figure 1). When targeted
at an older age group, the intervention became more cost-effective (and vice versa). Reduction in
incidence of CHD was a key determinant of the ICER; the threshold RR of intervention versus control
in incidence of CHD was 0.972.
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Control 23.245 (23.089, 23.354) $6093 ($5288, $6998) 
QALY: quality adjusted life year; ICER: incremental cost-effectiveness ratio. 
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The PSA yielded similar results to the base case scenario, with the point estimate of the base
case falling well within the 95% CI (Table 2). The cost-effectiveness acceptability curve showed that if
the WTP/QALY was above $35,000, the intervention h d a >66% probability of being cost-effective
(Figure 2). The cost-effectiveness plane echoed these results, suggesting a significantly high probability
of being cost- ffective (Figure 3).
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Figure 3. Incremental cost-effectiveness plane. Note: QALY: quality-adjusted life year; WTP:
willingness to pay; AUD: Australia dollar. The y-axis represents the incremental costs of proposed
(with the workplace intervention for CVD prevention) vs. current scenarios (without the workplace
intervention for CVD prevention); the x-axis presents the incremental QALY gains of the proposed vs.
current scenarios. The workplace intervention has a probability of 85% being cost-effective.
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4. Discussion
Our study systemically reviewed the most recent evidence around the efficacy of workplace
delivered interventions, which aimed to reduce office-based workers’ sitting time leading to increased
standing and undertook a modelled economic evaluation to simulate the long-term health benefits
of such interventions in preventing CVD in Australia. One new trial was identified which informed
the effect size (i.e., increase in standing time) in the modelled cost-effectiveness analysis of workplace
intervention. This intervention was highly likely (>85%) to be cost-effective for primary prevention of
CVD in the Australian context.
Increasing evidence shows that excessive sedentary time is related to increased all-cause
and cardiovascular morbidity and mortality [39]. Preventative efforts have targeted sedentary
behaviour. Whilst national sedentary behaviour guidelines for Australia [40], Canada [41] and United
Kingdom [42] recommend that adults should minimise time spent being sedentary for extended
periods, no prescriptive recommendation has been provided about the maximum limit of sedentary
time. Recent meta-analyses and reviews have assessed the prospective evidence on the association
of sedentary behaviour with CVD outcomes [39,43]. These reviews have consistently suggested that
excessive sedentary behaviour is associated with increased incidence of CVD (pooled RR 2.47, 95% CI
1.44–4.24) [43] and higher CVD mortality (pooled HR 1.90, 95% CI 1.36–2.66) [43,44]. The American
Heart Association summarised the current evidence surrounding sedentary behaviour as a potential
risk factor for CVD [39]. Therefore, in order to provide more evidence to underpin the current
national sedentary behaviour guidelines, it is important to explore the quantitative association between
reduction in sitting time and long-term changes in CVD.
The current recommendation for primary prevention for CVD relates to assessment of the risk
factors [6]. For all persons with CVD risk factors, the first-line treatment is lifestyle behaviour-change,
which typically incorporates behavioural change counselling. However, it was reported that the current
recommendation for lifestyle behaviour-change interventions should be revisited due to their poor
value for money given marginal population health gains and a very high cost [26]. If an individual’s
CVD risk factors are above the level set for treatment, lipid-lowering, antihypertensive or antiplatelet
medication could be initiated, however treatment compliance is suboptimal, with an estimated 40%
dropout rate in the first 12 months [45]. Hence, there is a need to investigate more primary prevention
options for CVD, especially for people of working age. Workplaces offer the potential for generating
intrinsic social support and are well-positioned for the delivery of interventions designed to promote
population health. The active collaboration of workplace peers in making maintainable modifications
to achieve a healthy lifestyle, might reduce the individual effort and motivation needed to make
behavioural changes and result in a more sustainable long-term effects [46].
It is reported that a greater amount of sitting time together with prolonged sitting time was
negatively associated with changes in high density cholesterol (HDL), triglycerides and 2-hour post
load glucose [47], animal-based studies suggest that this deleterious effect might be contributed by the
reduction in lipoprotein lipase activity [43] and upregulated insulin resistance [48]. However, we did
not model the long-term health outcomes of reduced sedentary behaviour through a reduction in CVD
biomarkers (i.e., LDL, insulin resistance etc.) as there is no consistency in these outcomes [49], whereas
the increase in standing time is fairly consistent across studies.
To the best of our knowledge, our study is the first to assess the cost-effectiveness of interventions
to reduce sitting time as a primary prevention measure for CVD. The intervention effect was mediated
by increased standing time (i.e., reduction in sitting time was largely replaced by standing time), which
contributed to lower incidence of CVD events. Prior modelling studies of the primary prevention
of CVD adopted a similar model structure and showed that compared to current practice, medical
treatments including antihypertensive (i.e., ACE inhibitor, Calcium channel blocker etc.), lipid lowering
(statin) and antiplatelet (i.e., aspirin) drugs were normally cost-effective options when administered
to people with increased CVD risk [26]. First-line therapy using lifestyle program or dietary advice
targeted at similar populations was associated with an ICER much higher than $50,000/DALY, rendering
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them not cost-effective under an Australian healthcare system perspective [26]. Our intervention, on
the contrary, targeted at a general population office-based workforce not necessarily with increased risk
of CVD, yielded an ICER of $18,221/QALY, with a potential to avoid 230 incident non-fatal CHD events
and 50 incident non-fatal strokes per 10,000 population in Australia. A 2014 review pointed out that
replacing sedentary time with an equal amount of either sleep or light-intensity activity yielded similar
reductions in CVD biomarkers (2.2% reduction versus 2.4% reduction in insulin respectively) [50],
which suggests that the intervention effect of reducing sitting time is likely to be additive to other
interventions including promoting physical activity.
In order to formulate an evidence basis for guideline-making, we also tested the impact of
different reductions in sitting time (assumed 100% replaced by standing time) on long-term health
outcomes. If sitting time could be lowered by two hours per day across entire working age groups, the
intervention would become dominant (i.e., involve less cost and greater benefits). The number of total
avoided CVD event would be 290 non-fatal CHD per 10,000 population whereas no difference in the
number of non-fatal/fatal stroke (results generated from the economic model).
Our updated systematic review only identified one new study additional to the most recent
published review of workplace interventions to reduce sitting time [22]. Only interventions involving a
sit-and-stand desk with or without a counselling component were observed to be effective in reducing
sitting time and increasing standing time, whereas other interventions entailing computer reminders
or activity tracker did not result in significant between-group differences and therefore were not
modelled [22].
When considering national implementation of a preventative intervention, affordability is a key
concern. The cost of this multicomponent intervention is comparable to dietary advice and lifestyle
program [26]. In addition, given that its potential benefits are partly received by employers (i.e.,
increased productivity and reduced presenteeism) [51], it is reasonable to suggest that the program’s
implementation might be co-funded by employers to alleviate some of the burden on government.
This is the first study to model the impact of workplace interventions that has attempted to
assess the impact of reduced sedentary behaviour on CVD primary prevention. It translates the
short-term benefits observed during the trial (i.e., increase in standing time) into long-term clinical
outcomes (i.e., avoided CHD and stroke). It provides preliminary evidence underpinning future
recommendations around daily limits on sitting time. The key limitations of the study are, firstly,
the uncertainty around the sustainability of the intervention effect; sensitivity analyses were run to
test that. As suggested, intervention delivered in the workplace may be more maintainable than
other non-workplace delivered interventions. Secondly, only the first CVD event was modelled
and any subsequent events were omitted given the focus on primary prevention of CVD. Thirdly,
the likely relationship between reduced sedentary behaviour and improved metabolic biomarkers
(i.e., lipids) was not accounted for in the model given the lack of consensus about the association
between sedentary behaviour and lipid level. Fourthly, it is worth noting that, given the potential link
between prolonged standing and increased risk of vascular and musculoskeletal issues [52], we need
to emphasise the importance of intermittently alternating standing with periods of sitting and physical
activity to minimise such risks. Fifthly, the effect size of the workplace-delivered intervention was
heavily weighted on the study by Healy [19], which is not uncommon when deriving an effect size from
a meta-analysis. However, there is little evidence to suggest that Australian have attitudes towards
adopting changes/new interventions that might be different to other cultures. With this generalisable
intervention impact, one can populate the economic model with local costs and incidences of CVD
to generate the country-specific ICER for country of interest within an international context. Lastly,
caution needs to be applied when interpreting the results from this study. While reduced sedentary
behaviour is linked to better CVD health [53], in the current modelled study, we have assumed that
the change in sedentary behaviour is mediated by the increase in standing at workplace. However,
it should be acknowledged that workplace interventions whereby reduced sitting is achieved increases
in physical activity (stepping) are likely to be more favourable in relation to CVD prevention.
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5. Conclusions
A workplace-delivered intervention employing a sit-and-stand desk component is a cost-effective
option for primary prevention of CVD in the Australian context. The benefit was derived from
reductions in time spent sitting that resulted in small increases in standing time in the workplace. This
offers a new option and location in the campaign against the growing burden of CVD. The affordability
of this intervention could be improved by partnerships with employers.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-4601/16/5/834/s1,
Figure S1: Illustration of Markov model structure, Figure S2: Forest plot of meta-analysed results.
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Appendix A
Search Strategies
Our updated literature search initially identified 579 number of citations published between
August 2017 and July 2018 (Embase: 425 hits; Medline complete and PsyInfo visa EbscoHost: 172 hits).
After screening the titles and abstracts, 475 of articles were excluded due to irrelevance. Eleven
of articles were reviewed on the full-text basis, among them, nine of papers were excluded due to
the ineligible study design (n = 5), wrong outcome (n = 2), and different setting of interest (n = 2).
Eventually, only one studies [37] were included into the quantitative analysis of the current study.






#4 seated NEAR/1 posture
#5 chair:ab,ti OR desk:ab,ti
#6 chair:ab,ti
#7 desk:ab,ti
#8 office AND inactiv*
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#10 ’work’/de OR work
#11 work*
#12 ’occupation’/de OR occupation
#13 employe*
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#21 #15 OR #16 OR #17 OR #18 OR #19 OR #20
#22 #9 AND #14 AND #21
#23 #22 AND [embase]/lim
#24 #23 AND [humans]/lim AND [embase]/lim
Medline + PsyInfo (Via EBSCOhost Data Base)
#1 (work[tw] OR works*[tw] OR work’*[tw] OR worka*[tw] OR worke*[tw] OR workg*[tw] OR worki*[tw] OR
workl*[tw] OR
workp*[tw] OR occupation*[tw] OR employe*[tw])
#2 (effect*[tw] OR control[tw] OR controls*[tw] OR controla*[tw] OR controle*[tw] OR controli*[tw] OR
controll*[tw] OR evaluat*[tw] OR intervention*[tw] OR program*[tw] OR compare*[tw])
#3 (sedentary OR sitting) OR seated posture OR chair[tiab] OR desk[tiab] OR (office AND inactiv*)
#4 (animals [mh] NOT humans [mh])
#5 #1 AND #2 AND #3 NOT #4
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Figure A1. PRISMA Flow Chart. * [37]. Figure A1. PRISMA Flow Chart. * [37].
Int. J. Environ. Res. Public Health 2019, 16, 834 13 of 17
Table A1. Model Parameters.
Parameters in the Model Value Used in the Model Source
Cost
Intervention $431 Gao et al., 2018 [51]
Incident stroke $23,581 IHPA *
Prevalent stroke $3201 Lim et al., 2005
Incident CHD $17,863 IHPA *
Prevalent CHD $4539 Lim et al., 2005
Utility weight
CHD 0.86 Cobiac et al., 2012 [26]
Stroke 0.76 Cobiac et al., 2012 [26]
* National Hospital Cost Data Collection, Independent hospital Pricing Authority (IHPA) [54]. CHD: coronary
heart disease.





Study duration: 18 months
Dropout: 0% (100% retention)
Location: Two units of a university, located in different buildings in the US
Recruitment: Employees in each worksite were invited to participate via
email lists. Participants signed consent form.
Participants
Population: full time office workers (18–65 years old)
Intervention group: 24 participants
Control group: 12 participants
Demographics:
Mean age: 39.1 (SD 11.3); female 70.8%.
Interventions
Duration of intervention: 4 months
Intervention: Each participants received a sit-stand workstation at their
primary work location. Three additional treadmill workstations were installed
in common areas. E-Newsletters for social support and maintaining progress
were sent to all staffs.
Control: Staffs received newsletter as in intervention arm but no
environmental changes were made.
Outcomes
Outcome name, measurement time/tool (units of measurement)
• Posture and activity were measured by accelerator. Outcomes reported
in minutes/ day for each period of total sitting, total standing, total LPA,
total MVPA, sit-to-stand transitions, time accrued in prolonged sitting.
• Cardio-metabolic biomarkers were evaluated by BMI. Blood pressure
was taken twice in consistent time and manner for each participants. Full
lipid profile with total cholesterol, high-density lipoprotein and
low-density lipoprotein as well as high-sensitivity C-reactive protein,
triglycerides, plasma glucose, and insulin levels were measured.
• Productivity loss was evaluated using questionnaires.
• Participants’ acceptance were evaluated by short interviews for
intervention arm.
Notes
This study was funded in part by the Virginia G. Piper Charitable Trust and
the Steelcase Corporation. First author is supported by the Fundamental
Research Funds for the Central Universities in China (GK201603128). Other
authors are supported by the National Institute of Health (R01CA198971).




Bias Authors’ judgement Support for judgement
Random sequence
generation (selection bias) High risk
Randomisation was not done as participants in
intervention and control groups were selected from
different location of one workplace.
Allocation concealment
(selection bias) High risk
Intervention and control groups were selected from
two separate locations. However no information
on allocation concealment












Low risk Virtually no attrition
Selective reporting
(reporting bias) Low risk
All outcomes mentioned in the method section
were reported. Study protocol was not available.
Baseline
comparability/imbalance Low risk
No significant difference between groups at
baseline was detected.
Validity of outcome measure Low risk
All questionaries used were validated and relevant
to China context. But physical activity and
sedentary time were measured by accelerators.
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